Does Dr. DORA ACHILLE have financial conflicts of interest?

Dr. DORA ACHILLE (DPM) has received a total of $572 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $572 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. DORA ACHILLE?

According to CMS Open Payments data, Dr. DORA ACHILLE received funding from SMITH+NEPHEW ($104), MELINTA THERAPEUTICS ($76), and NABRIVA THERAPEUTICS, PLC ($57).

Does Dr. DORA ACHILLE receive research grants or speaking fees?

Dr. DORA ACHILLE has received $572 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. DORA ACHILLE

DPMReal-Time Hydrated

Specialty: Podiatrist, Primary Podiatric Medicine

Practice Location: FLOWER MOUND, TX 75022

NPI Number: 1013952514

LIFETIME INDUSTRY VALUE

$572

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ACHILLE is a verified Podiatrist, Primary Podiatric Medicine practitioner based in FLOWER MOUND, TX.

Between 2021 and 2025, Dr. ACHILLE had an overall industry promotional and research financial footprint of $572 as recorded in the federal CMS Open Payments database.

$572 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ACHILLE's primary funding source is SMITH+NEPHEW, which accounts for $104 (representing 18.2% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SMITH+NEPHEW

Rank 1

$104

18.2%

MELINTA THERAPEUTICS

Rank 2

$76

13.3%

NABRIVA THERAPEUTICS, PLC

Rank 3

$57

10%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.